INR 850.8
(-1.08%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 14.02 Billion INR | 1.66% |
2022 | 6.33 Billion INR | 42.3% |
2021 | 4.45 Billion INR | 12.79% |
2020 | 3.94 Billion INR | 19.59% |
2019 | 3.3 Billion INR | 0.09% |
2018 | 3.29 Billion INR | 64.95% |
2017 | 2 Billion INR | -24.81% |
2016 | 2.66 Billion INR | -12.53% |
2015 | 3.04 Billion INR | 48.63% |
2014 | 2.04 Billion INR | 31.24% |
2013 | 1.55 Billion INR | 43.55% |
2012 | 1.08 Billion INR | 41.59% |
2011 | 767 Million INR | 139.69% |
2010 | 320 Million INR | -23.99% |
2009 | 421 Million INR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 662 Million INR | -69.32% |
2024 Q2 | 1.29 Billion INR | 95.77% |
2023 Q3 | 1.35 Billion INR | -18.88% |
2023 Q1 | 1.25 Billion INR | -43.74% |
2023 Q2 | 1.67 Billion INR | 33.6% |
2023 FY | 6.44 Billion INR | 1.66% |
2023 Q4 | 2.15 Billion INR | 58.91% |
2022 Q4 | 2.22 Billion INR | 46.51% |
2022 FY | 6.33 Billion INR | 42.3% |
2022 Q1 | 901 Million INR | -44.0% |
2022 Q2 | 1.44 Billion INR | 60.82% |
2022 Q3 | 1.52 Billion INR | 4.9% |
2021 Q2 | 908 Million INR | 21.23% |
2021 FY | 4.45 Billion INR | 12.79% |
2021 Q3 | 1.05 Billion INR | 15.64% |
2021 Q1 | 749 Million INR | -62.32% |
2021 Q4 | 1.6 Billion INR | 53.24% |
2020 Q3 | 1.23 Billion INR | 22.62% |
2020 FY | 3.94 Billion INR | 19.59% |
2020 Q4 | 1.98 Billion INR | 60.84% |
2020 Q2 | 1 Billion INR | 36.77% |
2020 Q1 | 737 Million INR | -53.82% |
2019 FY | 3.3 Billion INR | 0.09% |
2019 Q2 | 1.07 Billion INR | 45.45% |
2019 Q1 | 737 Million INR | -43.7% |
2019 Q4 | 1.59 Billion INR | 37.0% |
2019 Q3 | 1.16 Billion INR | 8.68% |
2018 Q4 | 1.3 Billion INR | 13.83% |
2018 FY | 3.29 Billion INR | 64.95% |
2018 Q1 | 910 Million INR | -18.39% |
2018 Q2 | 1.05 Billion INR | 15.38% |
2018 Q3 | 1.15 Billion INR | 9.52% |
2017 FY | 2 Billion INR | -24.81% |
2017 Q4 | 1.11 Billion INR | 8.46% |
2017 Q3 | 1.02 Billion INR | 3.21% |
2017 Q2 | 996 Million INR | 22.51% |
2017 Q1 | 813 Million INR | -12.77% |
2016 Q3 | 986 Million INR | 4.78% |
2016 Q2 | 941 Million INR | 20.49% |
2016 Q1 | 781 Million INR | -17.18% |
2016 FY | 2.66 Billion INR | -12.53% |
2016 Q4 | 932 Million INR | -5.48% |
2015 Q4 | 943 Million INR | 20.43% |
2015 Q2 | 585 Million INR | 0.34% |
2015 Q1 | 583 Million INR | -7.75% |
2015 Q3 | 783 Million INR | 33.85% |
2015 FY | 3.04 Billion INR | 48.63% |
2014 FY | 2.04 Billion INR | 31.24% |
2014 Q3 | 575 Million INR | 21.44% |
2014 Q2 | 473.5 Million INR | 15.26% |
2014 Q1 | 410.8 Million INR | 0.0% |
2014 Q4 | 632 Million INR | 9.91% |
2013 FY | 1.55 Billion INR | 43.55% |
2012 FY | 1.08 Billion INR | 41.59% |
2011 FY | 767 Million INR | 139.69% |
2010 FY | 320 Million INR | -23.99% |
2009 FY | 421 Million INR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Alfavision Overseas (India) Limited | 9.28 Million INR | -150982.624% |
Biocon Limited | 50.83 Billion INR | 72.409% |
Blue Jet Healthcare Limited | 3.37 Billion INR | -315.898% |
Concord Biotech Limited | 6.26 Billion INR | -123.975% |
Dishman Carbogen Amcis Limited | -13.9 Million INR | 100999.281% |
FERMENTA BIOTECH LIMITED | 1.06 Billion INR | -1213.269% |
GENOMIC VALLEY BIOTECH LIMITED | 1.27 Million INR | -1099253.322% |
Lyka Labs Limited | 29.13 Million INR | -48046.241% |
Panacea Biotec Limited | -309.7 Million INR | 4628.576% |
SAMSRITA LABS LIMITED | -1.49 Million INR | 936735.991% |
Servoteach Industries Limited | -785.00 INR | 1786624303.822% |
SMS Lifesciences India Limited | 359.47 Million INR | -3801.556% |
Supriya Lifescience Limited | 1.57 Billion INR | -792.374% |
TAKE Solutions Limited | -213.49 Million INR | 6669.394% |
Titan Biotech Limited | 315.89 Million INR | -4339.724% |
Transgene Biotek Limited | -7.08 Million INR | 197941.727% |
Vanta Bioscience Limited | -31.83 Million INR | 44151.134% |